- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-03-0023613

Maxicure Pharma Private Limited
About Maxicure Pharma Private Limited
Data last updated:
Maxicure Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51397KA2020PTC138914. Its GSTIN is 29AANCM8396H1ZK (Karnataka). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pranjal Jaiswal and Manoj Kumar Pandey.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C/O Pranjal Jaiswal 27 Bank Colony 1st Main 5th Cross Btm Layout 2nd, Bangalore, Karnataka, India – 560076.
As per the financials filed for FY 2024, the company reported a revenue of ₹37.99 Lakh, a growth of 39% compared to the previous year. For the same year it recorded a net profit of ₹36,913 (net margin 1%) and EBITDA of ₹48,959 (EBITDA margin 1.3%). Revenue has grown at a compounded annual rate (CAGR) of 79% over three years.
Maxicure Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0023613).
Company details
Recognitions & Rankings of Maxicure Pharma
Contact details
Maxicure Pharma Private Limited's registered office is in Bangalore, Karnataka.
- Registered AddressC/O Pranjal Jaiswal 27 Bank Colony 1st Main 5th Cross Btm Layout 2nd, Bangalore, Karnataka, India – 560076
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Maxicure Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Maxicure Pharma Private Limited, buy the company report.
Financials of Maxicure Pharma Private Limited
FY 2024 filings availableMaxicure Pharma Private Limited reported revenue of ₹37.99 Lakh (up 39% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 79% over three years, including 39% growth in the latest year. EBITDA rose 109% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹48,959 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹36,913 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.3% | |||
| Net Profit Margin | 1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Maxicure Pharma Private Limited, buy the company report.
Board of directors of Maxicure Pharma Private Limited
Maxicure Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pranjal Jaiswal | Director | 23 Sep 2020 | 6 Years 1 Months | Current |
| Manoj Kumar Pandey | Director | 23 Sep 2020 | 6 Years 1 Months | Current |
Peer comparison
Maxicure Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cherubic Laboratories Private Limited | ₹38.15 Lakh (FY 2024) | 37.0% | Cuttack, Odisha, India | |||
| VM Homoeo Source Private Limited | ₹38.07 Lakh (FY 2023) | 336.0% | New Delhi, Delhi, India | |||
| Maxicure Pharma Private Limitedthis company | ₹37.99 Lakh (FY 2024) | ₹36,913 | 1% | 39.0% | Bangalore, Karnataka, India | |
| Futurewell Pharmaceuticals Private Limited | ₹37.89 Lakh (FY 2024) | Kolkata, West Bengal, India | ||||
| Suprik Healthcare Private Limited | ₹37.72 Lakh (FY 2025) | 60.0% | Delhi, India |
To see the full peer comparison of Maxicure Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Maxicure Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maxicure Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Maxicure Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AANCM8396H1ZK | Karnataka | Active | 20 Oct 2020 |
| 10AANCM8396H1Z3 | Bihar | Active | 16 Oct 2020 |
To see the full GST registrations and return filing status of Maxicure Pharma Private Limited, buy the company report.
Recent activity
Maxicure Pharma Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Manoj Kumar Pandey was appointed as Director on 23 Sep 2020.
Frequently asked questions
Maxicure Pharma is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 September 2020 (6+ years old) and is registered under CIN U51397KA2020PTC138914.
Maxicure Pharma has 2 current directors:
- Pranjal Jaiswal - Director
- Manoj Kumar Pandey - Director
The latest financial statements of Maxicure Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Maxicure Pharma is 29AANCM8396H1ZK, registered in Karnataka. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 10AANCM8396H1Z3 (Bihar).
The CIN (Corporate Identification Number) of Maxicure Pharma is U51397KA2020PTC138914. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxicure Pharma was incorporated on 23 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Maxicure Pharma by revenue are Cherubic Laboratories Private Limited, VM Homoeo Source Private Limited, Futurewell Pharmaceuticals Private Limited, Suprik Healthcare Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Manoj Kumar Pandey was appointed as Director on 23 Sep 2020. Pranjal Jaiswal was appointed as Director on 23 Sep 2020.
Yes, Maxicure Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0023613).
The registered office of Maxicure Pharma is at CO Pranjal Jaiswal 27 Bank Colony 1st Main 5th Cross Btm Layout 2nd, Bangalore, Karnataka, India – 560076.
Maxicure Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

